(Q33241568)

24 July 2017

title

Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion (English)

1 reference

24 July 2017

Ismael Mingarro

4

0 references

María J. Gómara

object named as

María J Gómara

1

0 references

Maier Lorizate

2

object named as

Maier Lorizate

1 reference

24 July 2017

Nerea Huarte

3

1 reference

24 July 2017

Enrique Perez-Payá

5

1 reference

24 July 2017

José L Nieva

6

1 reference

24 July 2017

language of work or name

English

0 references

publication date

21 April 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

580

1 reference

24 July 2017

issue

11

1 reference

24 July 2017

page(s)

2561-2566

1 reference

HIV-1 membrane fusion: targets of opportunity

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Host factors and the pathogenesis of HIV-induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

HIV entry and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Development of HIV fusion inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Identification of the fusion peptide of primate immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Are fusion peptides a good model to study viral cell fusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Interactions of peptides with liposomes: pore formation and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi- and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Penetration into Target Cells by Synthetic Peptides Mimicking the N-Terminus of the HIV-1 Transmembrane Glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide: possible recognition of the fusion complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Design of bioactive and structurally well-defined peptides from conformationally restricted libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

H+- and Ca2+-induced fusion and destabilization of liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Interaction of the influenza hemagglutinin fusion peptide with lipid bilayers: area expansion and permeation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Conformational transitions of membrane-bound HIV-1 fusion peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Membrane fusion induced by the HIV type 1 fusion peptide: modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

The HIV Env-mediated fusion reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.003

10.1016/J.FEBSLET.2006.04.003

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference